Glenmede Trust’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,190
Closed -$495K 1347
2023
Q4
$495K Sell
16,190
-715
-4% -$19K ﹤0.01% 896
2023
Q3
$454K Buy
16,905
+6,876
+69% +$211K ﹤0.01% 869
2023
Q2
$255K Hold
10,029
﹤0.01% 1027
2023
Q1
$255K Sell
10,029
-5,634
-36% -$177K ﹤0.01% 1032
2022
Q4
$635K Buy
15,663
+201
+1% +$6.66K ﹤0.01% 770
2022
Q3
$510K Buy
15,462
+5,455
+55% +$220K ﹤0.01% 815
2022
Q2
$352K Hold
10,007
﹤0.01% 962
2022
Q1
$459K Sell
10,007
-11
-0.1% -$545 ﹤0.01% 920
2021
Q4
$664K Buy
10,018
+11
+0.1% +$756 ﹤0.01% 846
2021
Q3
$624K Sell
10,007
-31
-0.3% -$2.01K ﹤0.01% 836
2021
Q2
$831K Buy
10,038
+31
+0.3% +$2.31K ﹤0.01% 743
2021
Q1
$663K Sell
10,007
-11
-0.1% -$854 ﹤0.01% 771
2020
Q4
$768K Buy
10,018
+18
+0.2% +$1.15K ﹤0.01% 739
2020
Q3
$430K Sell
10,000
-28
-0.3% -$1.21K ﹤0.01% 827
2020
Q2
$432K Sell
10,028
-669
-6% -$23.6K ﹤0.01% 805
2020
Q1
$678K Hold
10,697
﹤0.01% 823
2019
Q4
$678K Buy
10,697
+54
+0.5% +$2.68K ﹤0.01% 823
2019
Q3
$299 Buy
10,643
+376
+4% +$11.1K ﹤0.01% 1033
2019
Q2
$272 Buy
10,267
+267
+3% +$5.86K ﹤0.01% 1072
2019
Q1
$183 Hold
10,000
﹤0.01% 1204
2018
Q4
$124 Hold
10,000
﹤0.01% 1288
2018
Q3
$191K Hold
10,000
﹤0.01% 1164
2018
Q2
$136K Hold
10,000
﹤0.01% 1174
2018
Q1
$36K Hold
10,000
﹤0.01% 1749
2017
Q4
$36K Buy
10,000
+5,000
+100% +$18.6K ﹤0.01% 1749
2017
Q3
$21K Hold
5,000
﹤0.01% 1941
2017
Q2
$9K Hold
5,000
﹤0.01% 2141
2017
Q1
$9K Hold
5,000
﹤0.01% 2141
2016
Q4
$7K Sell
5,000
-5,000
-50% -$21.3K ﹤0.01% 2168
2016
Q3
$73K Hold
10,000
﹤0.01% 1477
2016
Q2
$53K Hold
10,000
﹤0.01% 1553
2016
Q1
$48K Hold
10,000
﹤0.01% 1534
2015
Q4
$61K Hold
10,000
﹤0.01% 1503
2015
Q3
$57K Buy
10,000
+5,000
+100% +$31.4K ﹤0.01% 1544
2015
Q2
$35K Hold
5,000
﹤0.01% 1741
2015
Q1
$33K Hold
5,000
﹤0.01% 1798
2014
Q4
$36K Buy
+5,000
New +$34K ﹤0.01% 1856

Other funds holding ARWR

Glenmede Trust's ARWR Position: Q1 2024 in Review

Glenmede Trust sold out of Arrowhead Research (ARWR) in Q1 2024, closing a stake of 16,190 shares — an estimated $495K sold.

Glenmede Trust first reported a position in ARWR in Q4 2014 and held it in 37 quarters. The position peaked at $831K in Q2 2021. 274 funds tracked by Wall St. Rank hold ARWR as of Q1 2024.

  • Glenmede Trust reported no remaining Arrowhead Research position as of Q1 2024 after selling out during the quarter.
  • Glenmede Trust sold 16,190 Arrowhead Research shares in Q1 2024, an estimated $495K.
  • Glenmede Trust first reported a position in Arrowhead Research in Q4 2014 and held it in 37 quarters.
  • Glenmede Trust's Arrowhead Research position peaked at $831K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2024.

Based on Glenmede Trust's 13F filing for Q1 2024, filed 15 May 2024.